Molecules
The present invention relates to TLR2 agonist compounds and their compositions, and the use of such compounds and compositions in the prevention and/or treatment of respiratory infections, or diseases or conditions associated with viral or bacterial infections.
1. A compound, or a pharmaceutically acceptable salt or solvate thereof, wherein the compound is:
2. A compound, or a pharmaceutically acceptable salt or solvate thereof, wherein the compound is:
3. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, diluent, or excipient.
4. A pharmaceutical composition comprising the compound of claim 2 , or a pharmaceutically acceptable salt or solvate thereof; and a pharmaceutically acceptable carrier, diluent, or excipient.